{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/APOG/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T20:28:37.846Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10038,"canonical_name":"APOGEE ENTERPRISES, INC.","cik":"0000006845","uei":null,"lei":null,"duns":null,"ticker":"APOG"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":21},"count":21,"timeline":[{"ts":"2026-10-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — APOGEE ENTERPRISES, INC. — 2026-10-06","url_slug":"/sec/cik-0000006845/10-q/0000006845-26-000103","accession_number":"0000006845-26-000103","importance":45},{"ts":"2026-10-06","kind":"sec.filing","form_type":"8-K","title":"8-K — APOGEE ENTERPRISES, INC. — 2026-10-06","url_slug":"/sec/cik-0000006845/8-k/0000006845-26-000100","accession_number":"0000006845-26-000100","importance":35},{"ts":"2026-09-23","kind":"sec.filing","form_type":"8-K","title":"8-K — APOGEE ENTERPRISES, INC. — 2026-09-23","url_slug":"/sec/cik-0000006845/8-k/0000006845-26-000093","accession_number":"0000006845-26-000093","importance":35},{"ts":"2026-09-14","kind":"sec.filing","form_type":"8-K","title":"8-K — APOGEE ENTERPRISES, INC. — 2026-09-14","url_slug":"/sec/cik-0000006845/8-k/0000006845-26-000091","accession_number":"0000006845-26-000091","importance":35},{"ts":"2026-09-03","kind":"sec.filing","form_type":"8-K","title":"8-K — APOGEE ENTERPRISES, INC. — 2026-09-03","url_slug":"/sec/cik-0000006845/8-k/0000006845-26-000087","accession_number":"0000006845-26-000087","importance":35},{"ts":"2026-08-20","kind":"sec.filing","form_type":"S-8","title":"S-8 — APOGEE ENTERPRISES, INC. — 2026-08-20","url_slug":"/sec/cik-0000006845/s-8/0000006845-26-000084","accession_number":"0000006845-26-000084","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — APOGEE ENTERPRISES, INC. — 2026-08-05","url_slug":"/sec/cik-0000006845/8-k/0000006845-26-000070","accession_number":"0000006845-26-000070","importance":35},{"ts":"2026-08-05","kind":"sec.insider.a","reporter":"HAYEK JOSEPH B","title":null,"shares":2454,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-06","kind":"sec.insider.a","reporter":"Ede Christopher Willliam","title":"President, Architectural Glass","shares":5089,"price_per_share":39.79,"usd_value":202491,"security_title":"Common Stock","importance":15.20249131},{"ts":"2026-07-06","kind":"sec.insider.a","reporter":"Ede Christopher Willliam","title":"President, Architectural Glass","shares":5026,"price_per_share":39.79,"usd_value":199985,"security_title":"Common Stock","importance":15.19998454},{"ts":"2026-07-01","kind":"sec.filing","form_type":"8-K","title":"8-K — APOGEE ENTERPRISES, INC. — 2026-07-01","url_slug":"/sec/cik-0000006845/8-k/0000006845-26-000068","accession_number":"0000006845-26-000068","importance":35},{"ts":"2026-06-30","kind":"sec.filing","form_type":"10-Q","title":"10-Q — APOGEE ENTERPRISES, INC. — 2026-06-30","url_slug":"/sec/cik-0000006845/10-q/0000006845-26-000063","accession_number":"0000006845-26-000063","importance":45},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — APOGEE ENTERPRISES, INC. — 2026-06-29","url_slug":"/sec/cik-0000006845/8-k/0000006845-26-000060","accession_number":"0000006845-26-000060","importance":35},{"ts":"2026-06-26","kind":"sec.filing","form_type":"8-K","title":"8-K — APOGEE ENTERPRISES, INC. — 2026-06-26","url_slug":"/sec/cik-0000006845/8-k/0000006845-26-000058","accession_number":"0000006845-26-000058","importance":35},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — Parker Herbert K — 2026-06-26","url_slug":"/sec/cik-0001436496/4/0001436496-26-000004","accession_number":"0001436496-26-000004","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — Alvord Christina M — 2026-06-26","url_slug":"/sec/cik-0001692983/4/0001692983-26-000006","accession_number":"0001692983-26-000006","importance":30},{"ts":"2026-06-24","kind":"sec.form144","reporter":"Jewell Brent C","title":"Former Officer","shares":10148,"usd_value":405920,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001959173-26-004844","importance":40.081184},{"ts":"2026-06-24","kind":"sec.insider.a","reporter":"Parker Herbert K","title":null,"shares":2741,"price_per_share":41.96,"usd_value":115012,"security_title":"Common Stock","importance":15.11501236},{"ts":"2026-06-24","kind":"sec.insider.a","reporter":"Wagner Patricia K","title":null,"shares":2741,"price_per_share":41.96,"usd_value":115012,"security_title":"Common Stock","importance":15.11501236},{"ts":"2026-06-01","kind":"sec.filing","form_type":"SD","title":"SD — APOGEE ENTERPRISES, INC. — 2026-06-01","url_slug":"/sec/cik-0000006845/sd/0000006845-26-000048","accession_number":"0000006845-26-000048","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"SD/A","title":"SD/A — APOGEE ENTERPRISES, INC. — 2026-06-01","url_slug":"/sec/cik-0000006845/sd-a/0000006845-26-000050","accession_number":"0000006845-26-000050","importance":30}]}